Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL800 | 0.89 | ALDH1A1 (0.35) | ALDH1A1HTT | |
| SCHEMBL27500855 | 0.84 | ALDH1A1 (0.65) | ALDH1A1PLA2G4AFFAR3 | |
| Methylene Chloride SCHEMBL28135450 | 0.82 | HTT (0.31) | ALDH1A1HTT | |
| SCHEMBL29034649 | 0.82 | — | — | |
| Dimethyl Sulfoxide SCHEMBL9484693 | 0.81 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL801 | 0.80 | ALDH1A1 (0.43) | ALDH1A1TDP1HTT | |
| SCHEMBL18927364 | 0.79 | NAAA (0.47) | ALDH1A1NAAAHTT | |
| SCHEMBL9276 | 0.78 | — | — | |
| SCHEMBL182236 | 0.77 | ALDH1A1 (0.42) | ALDH1A1NAAATDP1FFAR3 | |
| SCHEMBL25238221 | 0.76 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200388882-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FLUORINATED ELECTROLYTE FORMULATIONS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| WO-2020132057-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION (US) | 2020-06-25 | — | — | WO | claimed |
| US-20200203711-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH ANHYDRIDE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-06-25 | — | — | US | claimed |
| US-20190027786-A1 | Electrolyte Solution for Secondary Batteries, and Secondary Battery | NEC CORPORATION (JP) | 2019-01-24 | — | — | US | claimed |
| EP-2125931-B1 | VINYL ENDS MEASURING METHOD | EASTMAN CHEM CO (US) | 2011-03-09 | — | — | EP | claimed |
| EP-2125931-A1 | VINYL ENDS MEASURING METHOD | Eastman Chemical Company (US) | 2009-12-02 | — | — | EP | claimed |
| WO-2008097416-A1 | VINYL ENDS MEASURING METHOD | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | WO | claimed |
| US-20080188003-A1 | Vinyl ends method | EASTMAN CHEMICAL COMPANY | 2008-08-07 | — | — | US | claimed |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4410788-B1 | CYANO COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI INST MATERIA MEDICA CAS (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-12531269-B2 | Silicon-based energy storage devices with fluorinated electrolyte formulations | ENEVATE CORPORATION (US) | 2026-01-20 | — | — | US | disclosed |
| US-12435080-B2 | sGC stimulators | TISENTO THERAPEUTICS INC. (US) | 2025-10-07 | — | — | US | disclosed |
| US-12405532-B2 | Polymer and composition for forming an anti-reflective film and method of manufacturing an integrated circuit device using the anti-reflective film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-09-02 | — | — | US | disclosed |
| US-20250260063-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | DAIKIN INDUSTRIES, LTD. (JP) | 2025-08-14 | — | — | US | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| EP-2125931-B1 | VINYL ENDS MEASURING METHOD | EASTMAN CHEM CO (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
| WO-2000026195-A1 | NOVEL AMINO ACID HETEROCYCLIC AMIDE DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12531269-B2 | Silicon-based energy storage devices with fluorinated electrolyte formulations | SLC9A2, SLC9A1, HCN2 | ALDH1A1 3495/4885NAAA 1233/4885PLA2G4A 3113/4885 |
| US-12435080-B2 | sGC stimulators | GUCY1A2, PRKG1, PDE2A | ALDH1A1 2355/4885NAAA 2943/4885PLA2G4A 389/4885 |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | ASH2L, OLA1, ODC1 | ALDH1A1 1584/4885NAAA 3018/4885PLA2G4A 3747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.